RELATED CONTENT
NEWS
- Promedior's new $21.5M series D helps advance fibrosis portfolio, including IPF and mylelofibrosis
- "Welcome home": Stromedix buy brings fibrosis drug back to Biogen
- BMS accesses fibrosis programme in $325 million deal for Amira
- InterMune clinches $55m deal to offload waning Actimmune
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

